Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 May;40(2):691–695. doi: 10.1128/iai.40.2.691-695.1983

Response of mouse intestinal loop to botulinum C2 toxin: enterotoxic activity induced by cooperation of nonlinked protein components.

I Ohishi
PMCID: PMC264910  PMID: 6341246

Abstract

Botulinum C2 toxin, which is composed of two nonlinked protein components, components I and II, induced fluid accumulation in mouse intestinal loops. The secretory response to C2 toxin was initiated after a lag period of 1 to 2 h and increased gradually for at least 10 h. The activity of C2 toxin was enhanced by treatment with trypsin and abolished by neutralization with anti-component I or anti-component II sera. Neither component I nor component II alone induced the fluid accumulation in intestinal loops. The intestinal loop activity was demonstrated with the culture supernatants of strains of Clostridium botulinum types C and D that produced C2 toxin, but not with culture supernatants of strains that did not. None of the botulinum type A through F neurotoxins induced fluid accumulation in mouse intestinal loops. The results indicate that, in addition to lethal and vascular permeability activities, C2 toxin has an enterotoxic activity for which the cooperation of components I and II is necessary. The fluid accumulation in intestinal loops inoculated with C2 toxin was not diminished by removal of the toxin from the loops. Moreover, the secretory response was positive when intestinal lumina were exposed to component II followed by the removal of the component and inoculation with component I, but it was negative when the intestinal lumina were exposed to component I followed by the removal of the component and inoculation with component II. These results suggest that the secretory response of mouse intestinal loops to C2 toxin is induced by the binding of component II to the epithelial cell surfaces of the intestines and the consequent binding or penetration of component I into the cells.

Full text

PDF
691

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burrows W., Musteikis G. M. Cholera infection and toxin in the rabbit ileal loop. J Infect Dis. 1966 Apr;116(2):183–190. doi: 10.1093/infdis/116.2.183. [DOI] [PubMed] [Google Scholar]
  2. Craig J. P. A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera. Nature. 1965 Aug 7;207(997):614–616. doi: 10.1038/207614a0. [DOI] [PubMed] [Google Scholar]
  3. Eklund M. W., Poysky F. T. Activation of a toxic component of Clostridium botulinum types C and D by trypsin. Appl Microbiol. 1972 Jul;24(1):108–113. doi: 10.1128/am.24.1.108-113.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Evans D. G., Evans D. J., Jr, Pierce N. F. Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun. 1973 Jun;7(6):873–880. doi: 10.1128/iai.7.6.873-880.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Evans D. J., Jr, Evans D. G., Gorbach S. L. Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun. 1973 Nov;8(5):725–730. doi: 10.1128/iai.8.5.725-730.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hauschild A. H. Erythemal activity of the cellular enteropathogenic factor of Clostridium perfringens type A. Can J Microbiol. 1970 Aug;16(8):651–654. doi: 10.1139/m70-112. [DOI] [PubMed] [Google Scholar]
  7. Iwasaki M., Ohishi I., Sakaguchi G. Evidence that botulinum C2 toxin has two dissimilar components. Infect Immun. 1980 Aug;29(2):390–394. doi: 10.1128/iai.29.2.390-394.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jansen B. C., Knoetze P. C. The taxonomic position of Clostridium botulinum type c. Onderstepoort J Vet Res. 1977 Jun;44(2):53–54. [PubMed] [Google Scholar]
  9. Jansen B. C., Knoetze P. C. Tryptic activation of Clostridium botulinum type C beta toxin. Onderstepoort J Vet Res. 1971 Dec;38(4):237–238. [PubMed] [Google Scholar]
  10. Kitamura M., Sakaguchi S., Sakaguchi G. Purification and some properties of Clostridium botulinum type-E toxin. Biochim Biophys Acta. 1968 Oct 21;168(2):207–217. doi: 10.1016/0005-2795(68)90144-x. [DOI] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Mosley W. H., Aziz K. M. Serological evidence for the identity of the vascular permeability factor and ileal loop toxin of Vibrio cholerae. J Infect Dis. 1970 Mar;121(3):243–250. doi: 10.1093/infdis/121.3.243. [DOI] [PubMed] [Google Scholar]
  13. Ohishi I., Iwasaki M., Sakaguchi G. Purification and characterization of two components of botulinum C2 toxin. Infect Immun. 1980 Dec;30(3):668–673. doi: 10.1128/iai.30.3.668-673.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ohishi I., Iwasaki M., Sakaguchi G. Vascular permeability activity of botulinum C2 toxin elicited by cooperation of two dissimilar protein components. Infect Immun. 1981 Mar;31(3):890–895. doi: 10.1128/iai.31.3.890-895.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ohishi I., Sakaguchi G. Activation of botulinum toxins in the absence of nicking. Infect Immun. 1977 Aug;17(2):402–407. doi: 10.1128/iai.17.2.402-407.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ohishi I., Sakaguchi G. Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes. Infect Immun. 1980 May;28(2):303–309. doi: 10.1128/iai.28.2.303-309.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ohishi I., Sakaguchi G. Production of C2 toxin by Clostridium botulinum types C and D as determined by its vascular permeability activity. Infect Immun. 1982 Jan;35(1):1–4. doi: 10.1128/iai.35.1.1-4.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Oishi I., Sakaguchi G. Purification of Clostridium botuliunum type F progenitor toxin. Appl Microbiol. 1974 Dec;28(6):923–928. doi: 10.1128/am.28.6.923-928.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pierce N. F., Greenough W. B., 3rd, Carpenter C. C., Jr Vibrio cholerae enterotoxin and its mode of action. Bacteriol Rev. 1971 Mar;35(1):1–13. doi: 10.1128/br.35.1.1-13.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stark R. L., Duncan C. L. Biological characteristics of Clostridium perfringens type A enterotoxin. Infect Immun. 1971 Aug;4(2):89–96. doi: 10.1128/iai.4.2.89-96.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yamamoto K., Ohishi I., Sakaguchi G. Fluid accumulation in mouse ligated intestine inoculated with Clostridium perfringens enterotoxin. Appl Environ Microbiol. 1979 Feb;37(2):181–186. doi: 10.1128/aem.37.2.181-186.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES